Glatopa Injection, Solution
Product Images NDC 63629-8816

19 FDA label images from Bryant Ranch Prepack · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Glatopa (NDC 63629-8816). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural-formula (Glatopa 01)

Structural-formula (Glatopa 01)
Chemical structure diagram showing a polypeptide comprised of amino acids Glu, Ala, Lys, and Tyr, with associated chemical groups indicated, and listing the CAS number 147245-92-9, representing Glatiramer Acetate.*
FDA Label Image

Figure_01 (Glatopa 02)

Figure_01 (Glatopa 02)
A line graph showing the percentage of second exacerbations over time (in days) for two groups: one treated with Glatiramer Acetate Injection and one placebo group. The y-axis represents second exacerbation percentage from 0% to 55%, and the x-axis shows days from 0 to 1080. The graph includes a hazard ratio of 0.55 and p-value of 0.0005, indicating statistical data related to treatment effectiveness.*
FDA Label Image

Figure_02 (Glatopa 03)

Figure_02 (Glatopa 03)
A line graph comparing the cumulative median number of enhancing lesions over nine months between two groups: one receiving Glatiramer Acetate Injection and the other a placebo. The vertical axis measures the lesion count, and the horizontal axis represents time in months, showing a slower increase in lesions in the Glatiramer Acetate group compared to placebo.*
FDA Label Image

Figure-a (Glatopa 04)

Figure-a (Glatopa 04)
An instructional illustration depicting components of a Glatopa injection kit, including a sharps disposal container, syringe in blister package, injection diary, alcohol wipes, and cotton balls. The items are labeled and arranged on a flat surface.*
FDA Label Image

Figure-b (Glatopa 05)

Figure-b (Glatopa 05)
An instructional illustration depicting hands preparing a Glatopa 40 mg/mL subcutaneous injection solution. The image shows the technique of handling the syringe or injection device for administration.*
FDA Label Image

Figure-c-abdomen (Glatopa 06)

Figure-c-abdomen (Glatopa 06)
An instructional anatomical diagram illustrating the lower abdominal area of a human figure with a marked injection site for subcutaneous administration. The illustration emphasizes a circular area on the lower abdomen as the recommended injection location for the Glatopa 40 mg/mL subcutaneous injection.*
FDA Label Image

Figure-c-hips-and-arms (Glatopa 07)

Figure-c-hips-and-arms (Glatopa 07)
Illustration showing the posterior view of a human torso highlighting the upper arms as injection sites for subcutaneous administration. The image indicates appropriate areas on both arms for injection placement.*
FDA Label Image

Figure-c-arms (Glatopa 08)

Figure-c-arms (Glatopa 08)
An instructional illustration showing a person administering a subcutaneous injection into the upper arm, depicting the typical injection site for a Glatopa (Glatiramer Acetate) 40 mg/mL solution. The image highlights the upper arm area where the injection is to be given.*
FDA Label Image

Figure-c-thighs (Glatopa 09)

Figure-c-thighs (Glatopa 09)
An instructional illustration depicting the front and side areas of the thighs as recommended subcutaneous injection sites for Glatopa (Glatiramer Acetate) 40 mg/mL solution. The diagram highlights the upper thigh regions where the injection can be administered.*
FDA Label Image

Figure-d (Glatopa 10)

Figure-d (Glatopa 10)
An instructional illustration showing a hand pinching skin on a forearm, demonstrating a subcutaneous injection technique commonly used for administering injectable medications such as Glatopa (glatiramer acetate) 40 mg/mL solution.*
FDA Label Image

Figure-e (Glatopa 11)

Figure-e (Glatopa 11)
Instructional illustrations showing a hand holding a pen-like object in three different positions, demonstrating how to hold and manipulate the device during use. Each image focuses on different hand grips and angles.*
FDA Label Image

Figure-f (Glatopa 12)

Figure-f (Glatopa 12)
An instructional diagram depicting a hand holding a syringe for subcutaneous injection, illustrating how to properly grasp the injection device. The image supports guidance for administration of Glatopa (Glatiramer Acetate) 40 mg/mL injection solution.*
FDA Label Image

Figure-g (Glatopa 13)

Figure-g (Glatopa 13)
An instructional illustration showing a hand injecting a subcutaneous injection into the lower abdomen using a syringe. The image demonstrates the appropriate site and technique for administering a Glatopa (glatiramer acetate) injection.*
FDA Label Image

Figure-h (Glatopa 14)

Figure-h (Glatopa 14)
An instructional black-and-white line drawing showing a person preparing for a subcutaneous injection. One hand pinches the skin, while the other hand holds a syringe poised for injection into the pinched area, likely illustrating proper injection technique.*
FDA Label Image

Figure-i (Glatopa 15)

Figure-i (Glatopa 15)
An instructional illustration showing a hand holding a syringe for a subcutaneous injection, with the other hand preparing the injection site on the skin. The image represents the administration method for Glatopa (Glatiramer Acetate) 40 mg/mL injection, solution.*
FDA Label Image

Figure-j (Glatopa 16)

Figure-j (Glatopa 16)
An instructional line drawing showing a hand holding an injection device or syringe at an angle toward the skin of a person's arm, demonstrating subcutaneous administration technique.*
FDA Label Image

Figure-k (Glatopa 17)

Figure-k (Glatopa 17)
An instructional illustration showing a hand holding a syringe near the upper arm, demonstrating the subcutaneous injection technique intended for Glatopa (glatiramer acetate) injection, solution 40 mg/mL.*
FDA Label Image

Figure-l (Glatopa 18)

Figure-l (Glatopa 18)
An instructional or informational illustration showing a biohazard sharps container used for the safe disposal of needles and other medical sharps. The container is square-shaped with a lid and displays a prominent biohazard symbol on the front.*
FDA Label Image

Label (Lbl636298816)

Label (Lbl636298816)
The label for Glatopa (glatiramer acetate injection) 40 mg/mL solution for subcutaneous injection by Bryant Ranch Prepack. The label states it contains 12 single-dose pre-filled syringes and includes storage instructions to keep refrigerated and protected from light. The label also lists mannitol 40 mg as an inactive ingredient and features the NDC 63629-8816-1 barcode and BRP Pharmaceuticals logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.